José Mario González Meljem holds a degree in Biotechnology Engineering with a specialisation in Molecular Biology from Tecnológico de Monterrey since 2010. Searching to become a life sciences researcher, he obtained an international postgraduate CONACYT scholarship and attained in 2012 a Master's degree in Biosciences focused on Stem Cells and Developmental Biology from University College London. During this time, he joined the laboratory of Dr. Juan Pedro Martinez Barberá in the UCL Institute of Child Health, where he studied the role of the CXCR4 chemokine receptor in the development of the pituitary gland, as well as in the origin of paediatric pituitary tumours known as craniopharyngiomas. He then obtained in 2017 a PhD. in Developmental Biology and Cancer. His doctorate´s thesis consisted in characterising the role of cellular senescence in the pathogenesis of craniopharyngiomas. He later joined the National Institute of Geriatrics in Mexico City as a researcher in medical sciences where he started a research line and several collaborations aimed at studying cellular senescence in the ageing neuroendocrine system. At the same time, he joined Tecnológico de Monterrey CCM as an adjunct lecturer, as well as the UNAM National Institute for Biomedical Research as an invited lecturer for postgraduate courses on genomics. In January 2019 he became a full-time lecturer at Tec de Monterrey and is now a lecturer-researcher in the Bioengineering Department. He is a member of the Translational Omics Research Focus Group where his main research interest is the study of cellular senescence in cancer and ageing.